Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture

Nat Commun. 2018 Nov 15;9(1):4795. doi: 10.1038/s41467-018-07071-7.

Abstract

Aortic intramural hematoma (IMH) can evolve toward reabsorption, dissection or aneurysm. Hypertension is the most common predisposing factor in IMH and aneurysm patients, and the hypertensive mediator angiotensin-II induces both in mice. We have previously shown that constitutive deletion of Rcan1 isoforms prevents Angiotensin II-induced aneurysm in mice. Here we generate mice conditionally lacking each isoform or all isoforms in vascular smooth muscle cells, endothelial cells, or ubiquitously, to determine the contribution to aneurysm development of Rcan1 isoforms in vascular cells. Surprisingly, conditional Rcan1 deletion in either vascular cell-type induces a hypercontractile phenotype and aortic medial layer disorganization, predisposing to hypertension-mediated aortic rupture, IMH, and aneurysm. These processes are blocked by ROCK inhibition. We find that Rcan1 associates with GSK-3β, whose inhibition decreases myosin activation. Our results identify potential therapeutic targets for intervention in IMH and aneurysm and call for caution when interpreting phenotypes of constitutively and inducibly deficient mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology
  • Aorta / drug effects
  • Aorta / metabolism
  • Aorta / pathology
  • Aortic Dissection / genetics*
  • Aortic Dissection / metabolism
  • Aortic Dissection / pathology
  • Aortic Dissection / prevention & control
  • Aortic Rupture / genetics*
  • Aortic Rupture / metabolism
  • Aortic Rupture / pathology
  • Aortic Rupture / prevention & control
  • Calcium-Binding Proteins
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Gene Deletion
  • Gene Expression Regulation
  • Genetic Predisposition to Disease
  • Glycogen Synthase Kinase 3 beta / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 beta / genetics*
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Hematoma / genetics*
  • Hematoma / metabolism
  • Hematoma / pathology
  • Hematoma / prevention & control
  • Humans
  • Hypertension / drug therapy
  • Hypertension / genetics*
  • Hypertension / metabolism
  • Hypertension / pathology
  • Intracellular Signaling Peptides and Proteins / deficiency
  • Intracellular Signaling Peptides and Proteins / genetics*
  • Male
  • Mice
  • Mice, Knockout
  • Muscle Proteins / deficiency
  • Muscle Proteins / genetics*
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / pathology
  • Primary Cell Culture
  • Protein Isoforms / deficiency
  • Protein Isoforms / genetics
  • Protein Kinase Inhibitors / pharmacology
  • rho-Associated Kinases / antagonists & inhibitors
  • rho-Associated Kinases / genetics*
  • rho-Associated Kinases / metabolism

Substances

  • Antihypertensive Agents
  • Calcium-Binding Proteins
  • DSCR1 protein, mouse
  • Intracellular Signaling Peptides and Proteins
  • Muscle Proteins
  • Protein Isoforms
  • Protein Kinase Inhibitors
  • Glycogen Synthase Kinase 3 beta
  • rho-Associated Kinases